1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) MARCH 2, 1998
--------------------------------
SRS LABS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-21123 33-0714264
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2909 DAIMLER STREET, SANTA ANA, CALIFORNIA 92705
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (949) 442-1070
------------------------------
NOT APPLICABLE
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
2
The undersigned registrant hereby amends, to the extent set forth
herein, the registrant's Current Report on Form 8-K dated March 12, 1998, and
filed with the Securities and Exchange Commission on March 13, 1998.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements of Business Acquired.
The audited consolidated financial statements of Valence
Technology Inc., a British Virgin Islands company
("Valence"), for the ten months ended January 31, 1998 and
for the year ended March 31, 1997, and the related
Independent Auditors' Report, are filed as Exhibit 99.1 to
this Form 8-K/A and are incorporated herein by reference.
(b) Pro Forma Financial Statements.
The unaudited pro forma consolidated condensed financial
statements of SRS Labs, Inc., a Delaware corporation ("SRS
Labs"), for the twelve months ended December 31, 1997 and
the three months ended March 31, 1998 reflecting the
acquisition of Valence are filed as Exhibit 99.2 to this
Form 8-K/A and are incorporated herein by reference.
(c) Exhibits.
99.1 Audited consolidated financial statements of
Valence for the ten months ended January 31,
1998 and for the year ended March 31, 1997, and
the related Independent Auditors' Report.
99.2 Unaudited pro forma consolidated condensed
financial statements of SRS Labs for the twelve
months ended December 31, 1997 and the three
months ended March 31, 1998 reflecting the
acquisition of Valence.
-2-
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SRS LABS, INC.,
a Delaware corporation
(Registrant)
Date: May 18, 1998 By: /s/ THOMAS C.K. YUEN
------------------------------
Thomas C. K. Yuen
Chairman of the Board and
Chief Executive Officer
-3-
4
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Audited consolidated financial statements of Valence for the
ten months ended January 31, 1998 and for the year ended March
31, 1997, and the related Independent Auditors' Report.
99.2 Unaudited pro forma consolidated condensed financial statements
of SRS Labs for the twelve months ended December 31, 1997 and
the three months ended March 31, 1998 reflecting the acquisition
of Valence.
-4-